---
id: ITE-2024-052
type: ITE
year: 2024
number: 52
created: 2025-08-10T13:35:41.023864
tags:
- ITE
- question
- ITE-2024
- 2024-exam
answer: C
topic: Psychiatry
related_articles:
- title: 'PubMed Entry'
  path: 2022/2022-09-ibrexafungerp-brexafemme-for-the-treatment-of-vulvovaginal-c.md
  similarity: 0.2
  link: '[[2022-09-ibrexafungerp-brexafemme-for-the-treatment-of-vulvovaginal-c|PubMed Entry]]'
- title: 'PubMed Entry'
  path: 2022/2022-07-abametapir-074-xeglyze-for-the-treatment-of-head-lice.md
  similarity: 0.2
  link: '[[2022-07-abametapir-074-xeglyze-for-the-treatment-of-head-lice|PubMed Entry]]'
- title: 'PubMed Entry'
  path: 2022/2022-12-another-study-fails-to-find-platelet-rich-plasma-injections.md
  similarity: 0.2
  link: '[[2022-12-another-study-fails-to-find-platelet-rich-plasma-injections|PubMed Entry]]'
- title: 'PubMed Entry'
  path: 2022/2022-07-treatment-of-chagas-disease-in-breastfeeding-dyads.md
  similarity: 0.2
  link: '[[2022-07-treatment-of-chagas-disease-in-breastfeeding-dyads|PubMed Entry]]'
- title: 'PubMed Entry'
  path: 2022/2022-08-cannabis-for-treatment-of-chronic-pain.md
  similarity: 0.2
  link: '[[2022-08-cannabis-for-treatment-of-chronic-pain|PubMed Entry]]'
topics:
- Psychiatry
---

# Question ITE-2024-052

## Question
A 24 -year-old female sees you for treatment of significant depression and associated hypomanic 
symptoms. She has been experiencing racing thoughts, agitation, and a decreased need for sleep.  
 
Which one of the following is CONTRAINDICATED in this patient?

## Answer Choices
**A)** Cariprazine (Vraylar) monotherapy
**B)** Quetiapine (Seroquel) monotherapy
**C)** Sertraline (Zoloft) monotherapy
**D)** Lurasidone (Latuda) plus valproic acid
**E)** Quetiapine plus lithium

## Correct Answer
**C**

## Explanation
Antidepressant monotherapy is contraindicated in patients with depression who have mixed features of associated hypomania or mania because it may precipitate or worsen mania. First -line treatment is mood stabilizers such as lithium, anticonvulsants, and antipsychotics.

## References
Marzani G, Neff AP. Bipolar disorders: evaluation and treatment. Am Fam Physician . 2021;103(4):227 -239.

## Related AAFP Articles
- [[2022-09-ibrexafungerp-brexafemme-for-the-treatment-of-vulvovaginal-c|PubMed Entry]] (Relevance: 20%)
- [[2022-07-abametapir-074-xeglyze-for-the-treatment-of-head-lice|PubMed Entry]] (Relevance: 20%)
- [[2022-12-another-study-fails-to-find-platelet-rich-plasma-injections|PubMed Entry]] (Relevance: 20%)
- [[2022-07-treatment-of-chagas-disease-in-breastfeeding-dyads|PubMed Entry]] (Relevance: 20%)
- [[2022-08-cannabis-for-treatment-of-chronic-pain|PubMed Entry]] (Relevance: 20%)

---
*Source: 2024 ABFM In-Training Examination*